Helicobacter pylori Infection, Intestinal Metaplasia, and Gastric Cancer Risk in Eastern Siberia

被引:27
|
作者
Tsukanov, Vladislav Vladimirovich [1 ]
Butorin, Nikolai Nikolaevich [2 ]
Maady, Ayas Sergeevich [3 ]
Shtygasheva, Olga Vladimirovna [2 ]
Amelchugova, Olga Sergeevna [1 ]
Tonkikh, Julia Leongardovna [1 ]
Fassan, Matteo [4 ]
Rugge, Massimo [4 ]
机构
[1] Russian Acad Med Sci, State Sci Med Res Inst No Problems, Siberian Div, Krasnoyarsk, Russia
[2] Khakass State Univ, Abakan, Russia
[3] Tyva Republican Hosp, Kyzyl, Russia
[4] Univ Padua, Dept Med Diagnost Sci & Special Therapies, Surg Pathol & Cytopathol Unit, I-35121 Padua, Italy
关键词
Helicobacter pylori; intestinal metaplasia; CagA; gastric cancer; EPIDEMIOLOGY; CAGA; CARCINOGENESIS; POLYMORPHISMS; PATHOGENESIS; PREVALENCE; DIAGNOSIS; JAPAN;
D O I
10.1111/j.1523-5378.2011.00827.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The incidence of gastric cancer (GC) is extremely high in Russia and eastern Siberia, where information on the epidemiology of Helicobacter pylori infection is fragmentary. Aims: To assess the prevalence of both H. pylori infection (including CagA status) and intestinal metaplasia (IM) in Russian and eastern Siberian populations carrying a different risk of GC. Materials and Methods: A sample of 2129 consecutive patients was considered, including 689 Europoids and 1440 Mongoloids (493 Evenks, 533 Khakass people, and 414 Tuvans), who all underwent serum sampling and upper gastrointestinal endoscopy. H. pylori status was established (ELISA, urease test, and histology), and IgG anti-CagA antibodies were assessed (ELISA) in H. pylori-positive cases. At least 3 biopsy samples per patient were considered, and IM was scored as present versus absent. The prevalence of H. pylori, CagA+ve status, and IM was compared with the incidence of GC according to the regional cancer registries. Results: The prevalence of H. pylori was similar for the Europoids and Mongoloids (93.6 vs 94.3%). The prevalence of CagA+ve infection was as follows: Europoids 61.2%, Evenks 36.4%, Khakass 44.0%, Tuvans 60.0% (p(1vs2) < .001; p(1vs3) < .001; p(2vs4) < .001; p(3vs4) < .001). The prevalence of IM was as follows: Europoids 10.7%, Evenks 5.1%, Khakass 9.8%, and Tuvans 23.4% (p(1vs2) = .001; p(1vs4) < .001; p(2vs4) < .001; p(3vs4) < .001). The incidence of GC (per 100,000 population/year) was as follows: Europoids 33.2; Evenks 18.2; Khakass 20.2; Tuvans 50.7 (p(1vs2) = 0.04; p(1vs3) = .05; p(2vs4) < .001; p(3vs4) < .001). Conclusion: H. pylori infection is consistently high in Russian and eastern Siberian populations; ethnicities with similar prevalence of CagA+ve status had different prevalence of IM and incidence of GC. As expected, IM prevalence correlated with the incidence of GC. Host-related and/or environmental factors may explain discrepancies between H. pylori status, the prevalence of IM, and the incidence of GC.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 50 条
  • [1] Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia
    M-S Wu
    C-T Shun
    W-C Lee
    C-J Chen
    H-P Wang
    W-J Lee
    J-T Lin
    British Journal of Cancer, 1998, 78 : 125 - 128
  • [2] Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia
    Wu, MS
    Shun, CT
    Lee, WC
    Chen, CJ
    Wang, HP
    Lee, WJ
    Sheu, JC
    Lin, JT
    BRITISH JOURNAL OF CANCER, 1998, 78 (01) : 125 - 128
  • [3] Helicobacter pylori infection and risk of gastric cancer in Korea;: Correlation with atrophic gastric and intestinal metaplasia.
    Kim, TH
    Chang, DK
    Lee, CH
    Jung, HC
    Song, IS
    Kim, CY
    GASTROENTEROLOGY, 1998, 114 (04) : A624 - A624
  • [4] Gastric atrophy and intestinal metaplasia in Helicobacter pylori infection
    Usta, Y
    Saltik-Temizel, IN
    Ozen, H
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2004, 38 (05): : 548 - 548
  • [5] Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
    De Re, Valli
    Orzes, Enrico
    Canzonieri, Vincenzo
    Maiero, Stefania
    Fornasarig, Mara
    Alessandrini, Lara
    Cervo, Silvia
    Steffan, Agostino
    Zanette, Giorgio
    Mazzon, Cinzia
    De Paoli, Paolo
    Cannizzaro, Renato
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2016, 7
  • [6] Helicobacter pylori infection and progression of gastric atrophy and intestinal metaplasia
    Furuta, T
    Takashima, M
    Arai, H
    Hanai, H
    Kaneko, E
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1998, 33 (09) : 1005 - 1005
  • [7] Intestinal metaplasia and gastric metaplasia in Helicobacter pylori (Hp) gastritis in a population with high risk for gastric cancer.
    Wong, BCY
    Ho, J
    Yuen, ST
    Lam, SK
    Ching, CK
    Hu, WHC
    Lai, KC
    Ong, LY
    Gao, Z
    Chen, JS
    Chen, BW
    Jiang, XW
    Hou, XH
    Lu, JY
    Wang, QH
    Hui, WM
    GASTROENTEROLOGY, 1997, 112 (04) : A682 - A682
  • [8] Gastric metaplasia and Helicobacter pylori infection
    Tovey, FI
    GUT, 1996, 38 (01) : 154 - 154
  • [9] The prevalence of Helicobacter pylori infection in Greek patients with gastric intestinal metaplasia
    Pilichos, C
    Demonakou, M
    Zougri, S
    Karadasi, E
    Kounios, D
    Grivas, E
    Barbatzas, C
    GUT, 2001, 49 : A44 - A44
  • [10] Interphase FISH as a biomarker of gastric cancer risk in Helicobacter pylori gastritis and intestinal metaplasia
    Kim, Byung-Wook
    Bronner, Mary P.
    Cho, Mee-Yon
    Lee, Bo-In
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S87 - S88